James N Topper Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for James N Topper.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of James N Topper. James N Topper is a Director in LA JOLLA PHARMACEUTICAL CO ($LJPC) and a Director in ProNAi Therapeutics Inc ($DNAI) and a Director in ANAPTYSBIO INC ($ANAB) and a Director in Allena Pharmaceuticals, Inc. ($ALNA) and a Director in ALPINE IMMUNE SCIENCES, INC. ($NVLS) and a Director in Aptinyx Inc. ($APTX) and a Director in Entasis Therapeutics Holdings Inc. ($ETTX) and a Director in Phathom Pharmaceuticals, Inc. ($PHAT) and an Chief Executive Officer in Frazier Lifesciences Acquisition Corp ($FLAC).
Address: 601 UNION STREET, SUITE 3200 SEATTLE 98101 WA
Companies in which James N Topper is an Insider
Allena Pharmaceuticals, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of James N Topper: Director
Holdings: 1,466,805 shares
Latest Transaction: Nov 18 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
ALPINE IMMUNE SCIENCES, INC.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of James N Topper: Director
Holdings: 2,571,450 shares
Current Value: $6,017,193
Latest Transaction: Jan 06 2020
$ALPN Market Capitalization: $36.22M
$ALPN Previous Close: $2.34
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
ANAPTYSBIO, INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of James N Topper: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Feb 12 2021
$ANAB Market Capitalization: $365.89M
$ANAB Previous Close: $18.54
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Aptinyx Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of James N Topper: Director
Holdings: 3,195,055 shares
Latest Transaction: Apr 02 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Entasis Therapeutics Holdings Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of James N Topper: Director
Holdings: 337,707 shares
Latest Transaction: Jan 22 2019
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Frazier Lifesciences Acquisition Corp
Industry: BLANK CHECKS [6770]
Position of James N Topper: Chief Executive Officer
Holdings: 501,000 shares
Latest Transaction: Dec 11 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
LA JOLLA PHARMACEUTICAL CO
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of James N Topper: Director
Holdings: 4,833,333 shares
Current Value: $94,104,994
Latest Transaction: May 23 2008
$LJPC Market Capitalization: $355.22M
$LJPC Previous Close: $19.47
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Phathom Pharmaceuticals, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of James N Topper: Director
Holdings: 0 shares
Latest Transaction: May 22 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Sierra Oncology, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of James N Topper: Director
Holdings: 5,925,926 shares
Latest Transaction: Feb 16 2017
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of James N Topper
Sentiment: All, ALNA, ALPN, ANAB, APTX, ETTX, FLAC, LJPC, PHAT, SRRA
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 12 2021 | ANAB | ANAPTYSBIO, INC | Topper James N | Director | Option Exercise | A | 29.70 | 11,000 | 326,700 | 11,000 | |
| Feb 12 2021 | ANAB | ANAPTYSBIO, INC | Topper James N | Director | Option Exercise | A | 29.70 | 11,000 | 326,700 | 11,000 | |
| Dec 11 2020 | FLAC | Frazier Lifescienc ... | Topper James N | Chief Executive Off ... | Option Exercise | A | 11.50 | 333,333 | 3,833,330 | 333,333 | |
| Dec 11 2020 | FLAC | Frazier Lifescienc ... | Topper James N | Chief Executive Off ... | Option Exercise | A | 11.50 | 167,000 | 1,920,500 | 167,000 | |
| Dec 11 2020 | FLAC | Frazier Lifescienc ... | Topper James N | Chief Executive Off ... | Buy | P | 10.00 | 1,000,000 | 10,000,000 | 1,000,000 | 0 to 1000 K |
| Dec 11 2020 | FLAC | Frazier Lifescienc ... | Topper James N | Chief Executive Off ... | Grant | A | 10.00 | 501,000 | 5,010,000 | 501,000 | 0 to 501 K |
| Nov 18 2020 | ANAB | ANAPTYSBIO, INC | Topper James N | Director | Buy | J | 0.00 | 26,354 | 0 | 80,812 | 54.5 K to 80.8 K (+48.39 %) |